MetaLINCS for Pharma

Legal Discovery for Lawsuits and Regulators

Within the pharmaceutical industry, the need to conduct electronic document discovery has never been greater. Pharmaceutical companies are facing an increasing number of lawsuits, from small matters to high-profile class actions. At the same time, they are subject to the discovery-intensive oversight of the Food and Drug Administration. Often regulatory and legal discovery requests cover several years and huge amounts of data, including emails. And legal discovery is getting more complex as new Federal Rules of Civil Procedure (FRCP) require that companies have more robust e-discovery processes.

The E-discovery Challenge

Despite the frequency and volume e-discovery requests, few pharmaceutical companies have a legal technology to streamline the process. Most pharmaceutical companies have very lean IT departments, and they do not want to devote resources to conducting e-discovery, including email discovery and email analysis. Instead, most rely on e-discovery litigation support service providers to conduct the time-consuming and expensive processing and review of electronic documents. As a consequence, pharmaceutical companies face rising e-discovery costs, lack a way to effectively analyze documents and conduct early case assessments, and are scrambling to comply with the new FRCP.

The MetaLINCS Solution

The MetaLINCS Enterprise E-discovery Suite delivers the capabilities pharmaceutical companies need to meet the e-discovery challenge and comply with the FRCP. With advanced e-discovery processing and review power, MetaLINCS reduces dependence on expensive litigation support service providers. It also makes it easy to conduct early case assessments and e-discovery analysis, including email analysis. MetaLINCS has the most powerful search capabilities available in a legal technology, which enables legal teams to work with massive amounts of data more easily. And because it requires very little maintenance or administration, MetaLINCS is ideally suited to lean IT environments.

The MetaLINCS Enterprise E-discovery Suite helps pharmaceutical companies:

• Reduce e-discovery costs by 50% and review time by 80%
• Automate e-discovery collection with scalable, low-maintenance technology
• Respond to FDA requests for information more quickly
• Integrate streamlined e-discovery processes with exiting litigation support service providers
• Meet FRCP requirements for data preservation, chain of custody, meet and confer sessions, and more robust processes
• Conduct early case assessments and develop effective case strategies sooner with document and email analysis